-
Another non-amyloid drug showing intriguing results is Dimebon from Medivation (nasdaq: MDVN - news - people ).
FORBES: Alzheimer's Drug Showdown
-
Medivation ( MDVN - news - people ).
FORBES: Boomers will fuel a bull market in health care stocks.
-
Among the largest underlying components of XBI, in trading today Spectrum Pharmaceuticals Inc ( NASD: SPPI) is up about 1.6%, Onyx Pharmaceuticals, Inc. ( NASD: ONXX) is trading flat, and Medivation Inc ( NASD: MDVN) is lower by about 0.1%.
FORBES: XBI, SPPI, ONXX, MDVN: ETF Outflow Alert
-
Among the largest underlying components of XBI, in trading today Spectrum Pharmaceuticals Inc ( NASD: SPPI) is up about 0.8%, ARIAD Pharmaceuticals, Inc. ( NASD: ARIA) is up about 0.5%, and Medivation Inc ( NASD: MDVN) is up by about 3.7%.
FORBES: XBI, SPPI, ARIA, MDVN: ETF Inflow Alert
-
Among the largest underlying components of XBI, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 2.6%, Amylin Pharmaceuticals, Inc. ( NASD: AMLN) is up about 0.7%, and Medivation Inc ( NASD: MDVN) is lower by about 0.5%.
FORBES: XBI, REGN, AMLN, MDVN: ETF Inflow Alert